TREATMENT OF MURINE CRYPTOCOCCOSIS WITH LIPOSOME-ASSOCIATED AMPHOTERICIN-B

被引：162
|
作者：
GRAYBILL, JR
CRAVEN, PC
TAYLOR, RL
WILLIAMS, DM
MAGEE, WE
机构：
[1] UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284
[2] UNIV TEXAS,HLTH SCI CTR,DEPT MICROBIOL,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,DIV ALLIED HLTH & LIFE SCI,SAN ANTONIO,TX 78285
来源：
JOURNAL OF INFECTIOUS DISEASES | 1982年 / 145卷 / 05期
关键词：
D O I：
10.1093/infdis/145.2.748
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：748 / 752
页数：5
相关论文
共 50 条
  • [1] TREATMENT OF EXPERIMENTAL MURINE CANDIDIASIS WITH LIPOSOME-ASSOCIATED AMPHOTERICIN-B
    AHRENS, J
    GRAYBILL, JR
    CRAVEN, PC
    TAYLOR, RL
    SABOURAUDIA-JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1984, 22 (02): : 163 - 166
  • [2] TREATMENT OF MURINE CRYPTOCOCCOSIS WITH MINOCYCLINE AND AMPHOTERICIN-B
    GRAYBILL, JR
    MITCHELL, L
    SABOURAUDIA-JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1980, 18 (02): : 137 - 144
  • [3] TREATMENT OF MURINE PULMONARY CRYPTOCOCCOSIS WITH KETOCONAZOLE AND AMPHOTERICIN-B
    IWEN, PC
    MILLER, NG
    MCFADDEN, HW
    JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (04): : 650 - 650
  • [4] TREATMENT OF EXPERIMENTAL MURINE CRYPTOCOCCOSIS - COMPARISON OF MICONAZOLE AND AMPHOTERICIN-B
    GRAYBILL, JR
    MITCHELL, L
    LEVINE, HB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (02) : 277 - 283
  • [5] PULMONARY CRYPTOCOCCOSIS - TREATMENT WITH AMPHOTERICIN-B
    DURANT, JR
    EPIFANO, LD
    EYER, SW
    ANNALS OF INTERNAL MEDICINE, 1960, 53 (03) : 534 - 547
  • [6] LIPOSOME-ENCAPSULATED AMPHOTERICIN-B IN THE TREATMENT OF EXPERIMENTAL MURINE CANDIDIASIS
    MIYAZAKI, T
    KOHNO, S
    KAKU, M
    KOGA, H
    YAMAGUCHI, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 161 (04): : 273 - 281
  • [7] TREATMENT OF MURINE DISSEMINATED CANDIDIASIS WITH LIPOSOME ENCAPSULATED AMPHOTERICIN-B (AMPHO)
    LOPEZBERESTEIN, G
    MEHTA, R
    HOPFER, R
    MEHTA, K
    KASI, L
    MILLS, K
    HERSH, E
    LUNA, M
    FAINSTEIN, V
    JULIANO, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 273 - 273
  • [8] TREATMENT OF CRYPTOCOCCOSIS - IS AMPHOTERICIN-B WHOLE STORY
    GRAYBILL, JR
    MITCHELL, L
    DRUTZ, DJ
    CLINICAL RESEARCH, 1978, 26 (03): : A396 - A396
  • [9] TREATMENT OF MURINE CANDIDOSIS AND CRYPTOCOCCOSIS WITH A UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B FORMULATION (AMBISOME)
    ADLERMOORE, JP
    CHIANG, SM
    SATORIUS, A
    GUERRA, D
    MCANDREWS, B
    MCMANUS, EJ
    PROFFITT, RT
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 63 - 71
  • [10] EFFICACY AND SAFETY OF AMPHOTERICIN-B COLLOIDAL DISPERSION COMPARED WITH THOSE OF AMPHOTERICIN-B DEOXYCHOLATE SUSPENSION FOR TREATMENT OF DISSEMINATED MURINE CRYPTOCOCCOSIS
    HOSTETLER, JS
    CLEMONS, KV
    HANSON, LH
    STEVENS, DA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) : 2656 - 2660
12345